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Editorial
The Impact Factor
Since its creation, the Brazilian Journal of Rheumatology (BJR) 
has overcome several challenges due to the persistence, ef-
fort and hard work of the journal’s editors, reviewers and 
contributors, aiming to achieve the currently high scien-
tifi c standards and consequent national and international 
prestige.
The fi rst major national recognition occurred in June 2004, 
with its inclusion in the collection of the Scientifi c Electronic 
Library Online - Brazil (SciELO-Brazil), which included BJR into 
an electronic database that contains a much selected collec-
tion of Brazilian scientifi c journals. 
When the journal was indexed in MEDLINE in 2010, BJR 
was included in a bibliographic database of the U.S. National 
Library of Medicine, which comprises over 19 million refer-
ences to articles in biomedical sciences from around the 
world, giving it international recognition.
Its indexation in the Web of Science, Thomson Reuters’ da-
tabase, in July 2012, was important for BJR to have its Impact 
Factor (IF) measured by the Journal of Citation Reports® (JCR), 
also by Thompson Reuters. And this IF, which was much an-
ticipated, has been attributed to BJR, being 0.864, establishing 
its place as the 12th national scientifi c health journal among 
indexed Brazilian publications. 
But what does that mean? What is the importance of the 
IF? The IF is a measure created by Eugene Garfi eld, the founder 
of the Institute for Scientifi c Information (ISI), aiming to refl ect 
the mean number of citations of scientifi c articles published 
in certain journals indexed by ISI. Since 1972, IFs have been 
calculated annually and the results are published in the JCR.
It is a very useful tool for ranking journals from the same 
area, by giving more importance to journals with a higher IF, 
to the detriment of those that have a lower IF. Thus, an article 
published in a journal with a higher IF will theoretically have 
greater impact, prestige and visibility. And for this reason, we 
observe the enormous effort by the authors to publish their 
results in journals of high IF. 
This shall be our goal from now on, to increase the IF of 
BJR. It won’t be easy, but we can count on the great collabora-
tion and effort of national and international authors, editors 
and reviewers to achieve such goal.
Max Victor Carioca Freitas
Roberto Ezequiel Heymann
Editors-in-chief
Brazilian Journal of Rheumatology
© 2013 Elsevier Editora Ltda. All rights reserved.
RBR 53(4) - Arquivo livro (Impressa).indb   321 21/10/2013   18:21:13
